Antiandrogen Therapy with Spironolactone for the Treatment of Hidradenitis Suppurativa

    July 2018 in “ Journal of The American Academy of Dermatology ”
    Nicole M. Golbari, Martina L. Porter, Alexa B. Kimball
    Studysummary This study observed that treatment with spironolactone significantly improved pain, inflammatory lesion count, and HS-PGA scores among female patients with hidradenitis suppurativa, suggesting its potential as an effective treatment option, even at lower doses, despite no change in Hurley stage or fistula count.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Endocrinologic Aspects of Hidradenitis Suppurativa Dermatologic Clinics · 2015
    2. A Case Series of 20 Women with Hidradenitis Suppurativa Treated with Spironolactone Australasian Journal of Dermatology · 2015
    3. Spironolactone in Dermatological Treatments Der Hautarzt · 2013
    4. Hidradenitis Suppurativa Treated With Finasteride Journal of Dermatological Treatment · 2005

    Related research 4

    1. Update on Hormonal Therapy in Hidradenitis Suppurativa Journal of Drugs in Dermatology · 2023
    2. Trends in the Prescribing Pattern of Spironolactone for Acne and Hidradenitis Suppurativa in Adolescents Journal of The American Academy of Dermatology · 2021
    3. Spironolactone Therapy for Hidradenitis Suppurativa Clinical and Experimental Dermatology · 2019
    4. A Case Series of 20 Women with Hidradenitis Suppurativa Treated with Spironolactone Australasian Journal of Dermatology · 2015